DRACP03467 |
Alyteserin-2a [A10W][N15k] |
ILGKLLSTAWGLLSkL |
16 |
Synthetic |
DRACP03468 |
Alyteserin-2a [A10W][G11k][N15k] |
ILGKLLSTAWkLLSkL |
16 |
Synthetic |
DRACP03469 |
Esculentin-2CHa (1-30) |
GFSSIFRGVAKFASKGLGKDLAKLGVDLVA |
30 |
Synthetic |
DRACP03470 |
Esculentin-2CHa (11-37) |
KFASKGLGKDLAKLGVDLVACKISKQC |
27 |
Synthetic |
DRACP03471 |
NS5A-derived peptide C5A |
SWLRDIWDWICEVLSDFK |
18 |
Synthetic |
DRACP03472 |
BmLAO-f1 |
IKFEPPLPPKKAH |
13 |
Synthetic |
DRACP03473 |
BmLAO-f2 |
KKFWEDDG |
8 |
Synthetic |
DRACP03474 |
BmLAO-f3 |
IYYPPNHNFP |
10 |
Synthetic |
DRACP03475 |
Peptide P [K7,14,22k; A12,20L] |
KWKSFLkTFKSLKkTVLHTLLkAISS |
26 |
Synthetic |
DRACP03479 |
Pleurocidin - D |
GwGsffkkaahvGkhvGkaalthyl |
25 |
Synthetic |
DRACP03480 |
Temporin-1DRa [H1K] |
KFLGTLVNLAKKIL |
14 |
Synthetic |
DRACP03481 |
|
KKLFKKGLKFL |
11 |
Synthetic |
DRACP03482 |
D Kalata-B1 |
GlpvcGetcvGGtcntpGctcswpvctrn |
29 |
Synthetic |
DRACP03485 |
Bactenecin-7 (1-35), Bac-7 (1-35) |
RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFP |
35 |
Synthetic |
DRACP03486 |
Bactenecin-7 (1-23) |
RRIRPRPPRLPRPRPRPLPFPRP |
23 |
Synthetic |
DRACP03487 |
Bactenecin-7 (1-16) |
RRIRPRPPRLPRPRPR |
16 |
Synthetic |
DRACP03488 |
P18 N-3L |
KWFKKIPKFLHLLKKF |
16 |
Synthetic |
DRACP03493 |
Buforin-2 (5-13)[17-20]2 |
RAGLQFPVGRLLRRLLR |
17 |
Synthetic |
DRACP03496 |
|
GXRKXKAXWH |
10 |
Synthetic |
DRACP03499 |
|
FSPQMLQDIIEKKTKIL |
17 |
Synthetic |
DRACP03500 |
|
FSPQMLQDIIEAATAIL |
17 |
Synthetic |
DRACP03505 |
Pep27 [E4W][R19W][R22W][R26W] |
MRKWFHNVLSSGQLLADKWPAWDYNWK |
27 |
Synthetic |
DRACP03507 |
KCM11 |
TWWRWW |
6 |
Synthetic |
DRACP03508 |
KCM12 |
KWRWIW |
6 |
Synthetic |
DRACP03509 |
KCM21 |
KWWWRW |
6 |
Synthetic |
DRACP03510 |
KRS22 |
WRWFIH |
6 |
Synthetic |
DRACP03511 |
Enfuvirtide, ENF, T-20, Fuzeon, DP-178 |
YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF |
36 |
Synthetic |
DRACP03512 |
LL-37 (15-32)[E1G], GF-17 |
GFKRIVQRIKDFLRNLV |
17 |
Synthetic |
DRACP03519 |
|
FP |
2 |
Synthetic |
DRACP03520 |
|
PW |
2 |
Synthetic |